Harbour Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.3M Buy
27,501
+719
+3% +$729K 0.39% 48
2025
Q4
$28.8M Buy
26,782
+8,255
+45% +$7.89M 0.58% 30
2025
Q3
$14.1M Buy
18,527
+2,669
+17% +$1.99M 0.32% 58
2025
Q2
$12.4M Buy
15,858
+3,074
+24% +$2.39M 0.31% 55
2025
Q1
$10.6M Buy
12,784
+317
+3% +$264K 0.3% 62
2024
Q4
$9.62M Buy
12,467
+3,031
+32% +$2.51M 0.28% 62
2024
Q3
$8.36M Buy
9,436
+1,441
+18% +$1.3M 0.25% 72
2024
Q2
$7.24M Buy
7,995
+236
+3% +$189K 0.24% 71
2024
Q1
$6.04M Buy
7,759
+186
+2% +$132K 0.21% 89
2023
Q4
$4.41M Buy
7,573
+1,297
+21% +$757K 0.18% 103
2023
Q3
$3.37M Sell
6,276
-550
-8% -$283K 0.17% 118
2023
Q2
$3.2M Buy
6,826
+175
+3% +$73.4K 0.16% 124
2023
Q1
$2.28M Buy
6,651
+112
+2% +$37.8K 0.12% 155
2022
Q4
$2.39M Buy
6,539
+3,103
+90% +$1.1M 0.15% 131
2022
Q3
$1.11M Hold
3,436
0.08% 256
2022
Q2
$1.11M Buy
+3,436
New +$1.03M 0.08% 256
2021
Q4
$2.29M Sell
8,272
-1,845
-18% -$468K 0.14% 160
2021
Q3
$2.34M Sell
10,117
-1,318
-12% -$325K 0.07% 241
2021
Q2
$2.63M Sell
11,435
-173
-1% -$34.8K 0.08% 219
2021
Q1
$2.17M Buy
+11,608
New +$2.27M 0.08% 237

Other funds holding LLY

Harbour Investments's LLY Position: Q1 2026 in Review

Harbour Investments increased its Eli Lilly (LLY) stake by 2.7% in Q1 2026, buying an estimated $729K and bringing the position to 27,501 shares worth $25.3M. The position accounts for 0.39% of the portfolio, ranked #48.

Harbour Investments first reported a position in LLY in Q1 2021 and has held it in 20 quarters since. The position peaked at $28.8M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Harbour Investments held 27,501 shares of Eli Lilly worth $25.3M as of Q1 2026.
  • Harbour Investments bought 719 Eli Lilly shares in Q1 2026, an estimated $729K.
  • Eli Lilly made up 0.39% of Harbour Investments's portfolio in Q1 2026, its #48 holding.
  • Harbour Investments first reported a position in Eli Lilly in Q1 2021 and has held it in 20 quarters since.
  • Harbour Investments's Eli Lilly position peaked at $28.8M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.